LJI Professor Stephen Schoenberger, Ph.D. LA JOLLA, CA—Scientists at La Jolla Institute for Immunology (LJI) and the University of Washington (UW) have discovered that patients with lupus have unusual ...
As part of the President’s Award Celebration, LJI leaders announced a $55 million fundraising campaign to launch a new ...
If you cannot defeat your enemy, start by learning how to make it less dangerous. I am interested in understanding how our T cells fight viruses we know, to be better prepared for the emerging ...
Dr. Kawakami has been using the high-affinity IgE receptor (FceRI) signaling in mast cells as a model system. Following his co-discovery of two Tec family PTKs, Btk and Itk, in mast cells, his group ...
As our knowledge of the FceRI-mediated signal transduction has grown for the last two decades, the need to study in vivo roles of this pathway in disease settings encouraged the Kawakami group to ...
A collaboration with various centers of the Human Immune Profiling Consortium (HIPC) to build upon the existing infrastructure of ImmPort, a publicly-available data repository, which includes ...
While an enormous number of genetic variants have been associated with risk for human disease, how these variants affect gene expression in various cell types remains largely unknown. To address this ...
In 2013, Dr. Vijayanand teamed up with Professor Christian Ottensmeier at the Cancer Center, University of Southampton, UK, to set up a large patient-centered cancer immunology program utilizing ...
LA JOLLA, CA—Scientists at La Jolla Institute for Immunology (LJI) have uncovered the structure and function of the first FDA-approved treatment for Zaire ebolavirus (Ebola virus). Inmazeb (REGN-EB3), ...
LA JOLLA, CA—In a new study published in Cell Host & Microbe, scientists at La Jolla Institute for Immunology (LJI) compared the immune response of individuals who received older versus newer versions ...
LA JOLLA, CA, and ROME, ITALY—La Jolla Institute for Immunology (LJI) and Link Campus University of Rome, Italy, and have signed a collaborative agreement as part of a strategic program aimed at ...
LA JOLLA, CA—A population of unconventional white blood cells has recently captured the attention of immunologists and clinicians alike. Unlike conventional T cells, which circulate throughout the ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results